Company: CXDO
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001654954-25-012585
Chunk: 28

Company: Crexendo, Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 1
Chunk 28
---
  1,421,594   3,008,617   2,126,143   3,217,402 Diluted weighted-average outstanding shares of common stock (C)  31,818,738   29,857,261   31,418,659   29,827,532                  Earnings per common share:                Basic (A/B) $0.05  $0.01  $0.13  $0.04 Diluted (A/C) $0.05  $0.00  $0.12  $0.04  For the three and nine months ended September 30, 2025 and 2024, the following potentially dilutive common stock, including awards granted under our equity incentive compensation plans, were excluded from the computation of diluted net income per share because including them would be anti-dilutive:    Three Months EndedSeptember 30,  Nine Months EndedSeptember 30,   2025  2024  2025  2024 Stock options  1,515,383   2,871,939   1,725,784   2,775,229 

4. Trade Receivables and Allowance for Credit Losses Our trade receivables balance consists of traditional trade receivables. Trade receivables were as follows (in thousands):   September 30,  December 31,   2025  2024 Gross trade receivables $4,892  $4,498 Less: allowance for credit losses  (144)  (146)Trade receivables, net $4,748  $4,352          Current trade receivables, net $4,748  $4,352 Long-term trade receivables, net  -   - Trade receivables, net $4,748  $4,352 

 18Table of Contents

The allowance for credit losses was as follows (in thousands): Balance at December 31, 2024 $146 Provision  48 Write-offs  (31)Recoveries and other  2 Balance at March 31, 2025 $165 Provision  27 Write